AYTU BIOPHARMA, INC·4

Nov 21, 9:30 AM ET

Oki Mark K 4

4 · AYTU BIOPHARMA, INC · Filed Nov 21, 2022

Insider Transaction Report

Form 4
Period: 2022-11-18
Oki Mark K
Chief Financial Officer
Transactions
  • Award

    Common Shares

    2022-11-18$0.23/sh+90,000$20,700190,000 total

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT